Article info

Download PDFPDF
Endotyping idiopathic pulmonary fibrosis should improve outcomes for all patients with progressive fibrotic lung disease
  1. Correspondence to Dr Gisli Jenkins, Respiratory Research Unit, Clinical Sciences Building, City Hospital Campus, Nottingham University Hospitals, Hucknall Road, Nottingham NG5 1PB, UK; gisli.jenkins{at}nottingham.ac.uk
View Full Text

Citation

Jenkins G
Endotyping idiopathic pulmonary fibrosis should improve outcomes for all patients with progressive fibrotic lung disease

Publication history

  • First published November 19, 2014.
Online issue publication 
September 01, 2022

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.